Efficacy of Anlotinib in Treating Progressive Glioblastoma: Insights From a Single-Center Study
{{output}}
BACKGROUND Glioblastoma (GBM) is the most common and aggressive malignant tumor in the central nervous system, with limited therapeutic options and poor prognosis. Anlotinib, a novel multi-targeted tyrosine kinase inhibitor, has shown promise in treating vario... ...
